3 completed, 2 recruiting. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 2 |
| Phase 1 | 1 | Completed 1 |
Follow Endometrial Stromal Sarcoma: new trials by email Literature Review of Endometrial Stromal Sarcoma trials Research Report on Endometrial Stromal Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ph 2 Elacestrant in ER Positive Uterine Sarcomas Elacestrant - Uterine Sarcoma, Uterine Leiomyosarcoma | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 30 | 2026-03-25 | 2026-05-22 |
| MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma MASCT-I, Doxorubicin, Ifosfamide - Leiomyosarcoma, Liposarcoma | Phase 2 | Recruiting | HRYZ Biotech Co. | 148 | 2024-02-21 | 2025-07-24 |
| A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients Selinexor - Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST) | Phase 1 | Completed | University Health Network, Toronto | 56 | 2021-03-29 | 2025-05-29 |
| FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study Fulvestrant - Endometrial Stromal Sarcoma, Adenosarcoma of Uterus | Phase 2 | Completed | Frederic Amant | 17 | 2019-03-13 | 2024-05-28 |
| AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma saracatinib - Adult Fibrosarcoma, Adult Leiomyosarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2008-02-01 | 2018-06-29 |
Sarcoma, Endometrial Stromal (5) · Leiomyosarcoma (3) · Sarcoma (3) · Adenosarcoma of the uterus (2) · Fibrosarcoma (2) · Histiocytoma, Malignant Fibrous (2) · Liposarcoma (2) · Neurofibrosarcoma (2) · Dermatofibrosarcoma (1) · Desmoplastic Small Round Cell Tumor (1) · Endometrial Neoplasms (1) · Hemangiosarcoma (1) · Perivascular Epithelioid Cell Neoplasms (1) · Rhabdomyosarcoma (1) · Sarcoma, Synovial (1)
Endometrial Stromal Tumors (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Genital Neoplasms, Female (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Complex and Mixed (5) · Neoplasms, Connective and Soft Tissue (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Uterine Diseases (5) · Uterine Neoplasms (5) · Endometrial Neoplasms (4)
Doxorubicin (1) · Fulvestrant (1) · Ifosfamide (1) · Injections (1) · RAD1901 (1) · elacestrant (1) · saracatinib (1) · selinexor (1)
Dana-Farber Cancer Institute (1) · Frederic Amant (1) · HRYZ Biotech Co. (1) · National Cancer Institute (NCI) (1) · University Health Network, Toronto (1)
Canada (2) · United States (2) · Belgium (1) · China (1) · Netherlands (1)
Albiruni Razak, M.D. (1) · Margaret von Mehren (1) · Suzanne George, MD (1) · Xing Zhang (1) · Zhang Xing (1)
2017 (1), N01CM62203 (1)